SV Health Investors Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 23
Professionals
  • Investments
  • 481
  • Portfolio
  • 56
  • Exits
  • 197
Exits

SV Health Investors General Information

Description

Founded in 1993, SV Health Investors is a venture capital firm based in Boston, Massachusetts. The firm seeks to invest in seed-stage, early-stage, later-stage, growth-stage, and public companies operating in biotechnology, healthcare services, dementia, medical technology & products, and digital health sectors in the United States and Europe.

Contact Information

Formerly Known As
SV Life Sciences
Year Founded
1993
Investor Status
Actively Seeking New Investments
Trade Association
National Venture Capital Association (NVCA)
Primary Investor Type
Venture Capital
Other Investor Types
Growth/Expansion
Primary Office
  • One Boston Place 201 Washington Street
  • Suite 3900
  • Boston, MA 02108
  • United States
+1 (617) 000-0000

SV Health Investors Investments & Acquisitions (481)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
QuellTX 29-Nov-2021 Early Stage VC 00000 Biotechnology Product Development 000000 000000000 00.0
0000000 0000000000 23-Nov-2021 0000 00000 000.00 Biotechnology Startup
0000000 0000000 17-Nov-2021 00000 00000 0000 Drug Discovery Clinical Trials - General
0000000 000000 09-Nov-2021 0000000000 BPO/Outsource Services Generating Revenue
0000000 0000000000 02-Nov-2021 00000 00000 0000 Drug Discovery Generating Revenue
000000 000000 21-Oct-2021 00000 00000 0000 Therapeutic Devices Generating Revenue 0000 0000000000
000000 27-Jul-2021 00000 00000 00000 Drug Discovery Generating Revenue 0000000 0000 00.0
000000 00000000000 16-Jul-2021 0000 00000 0000 Drug Discovery Startup 000000 000000000 00.0
Signal Home Health Care 12-Jul-2021 Buyout/LBO Elder and Disabled Care Generating Revenue 000000 00000
TRexBio 22-Jun-2021 Early Stage VC 000.00 Drug Discovery Startup 000000 000000000 00.0
You’re viewing 10 of 481 investments and acquisitions. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

SV Health Investors Exits (197)

Company Name Exit Date Exit Type Exit Size
EBR Systems 24-Nov-2021 IPO 000.00
0000000 000000 09-Nov-2021 0000000000
0000000 29-Oct-2021 000000000000000000 00000
00000 000000000000 22-Oct-2021 000 00000
0000000 30-Sep-2021 000000000000000000 00000
000000000 20-Aug-2021 000000000000000000
00000000 16-Jun-2021 0000000000
0000000 01-May-2021 000000000 00000000
HealthPRO Heritage 15-Mar-2021 Buyout/LBO
Vantia Therapeutics 09-Feb-2021 Bankruptcy: Liquidation
You’re viewing 10 of 197 exits. Get the full list »

SV Health Investors Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore SV Health Investors‘s full profile, request access.

Request a free trial

SV Health Investors Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

SV Health Investors Team (98)

Name Title Deals Funds Boards Office
Brent Faduski Chief Financial Officer Boston, MA
Paul Laviolette Managing Partner & Chief Operating Officer 00 0 00 Boston, MA
Catherine Bingham Managing Partner & Investment Committee Member 00 0 0 London, United Kingdom
Gregory Madden Managing Partner 0 0 0 Boston, MA
Michael Balmuth Managing Partner 00 0 0 Boston, MA
You’re viewing 5 of 98 team members. Get the full list »

SV Health Investors Co-Investors (206)

Name With Exits Lead Partner Series Industry
Dementia Discovery Fund 14 0 0 Series chart Industry bar
Alexandria Venture Investments 0 0 0 Series chart Industry bar
Amgen Ventures 0 0 Series chart Industry bar
OrbiMed 0 0 0 Series chart Industry bar
Sofinnova Partners 0 0 Series chart Industry bar
You’re viewing 5 of 206 co-investors. Get the full list »